NDAORALTABLETPriority Review
Lifecycle
Pre-Launch
Data completeness
0/8 — Limited
Priority Review
Drug data last refreshed 2w ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
This is a fixed-dose combination tablet containing lamivudine, stavudine, and nevirapine—three antiretroviral agents used to treat HIV infection. The combination targets HIV through nucleoside reverse transcriptase inhibition (lamivudine and stavudine) and non-nucleoside reverse transcriptase inhibition (nevirapine). This oral tablet formulation is designed for simplified, once-daily dosing in resource-limited settings.
Pre-Launch
Pre-launch status indicates this is an early-stage opportunity for team building in emerging markets, with potential for rapid scaling if approved and registered in target countries.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Joining this pre-launch product at Cipla positions you in the fast-growing affordable medicines sector serving emerging markets, with emphasis on regulatory navigation, health systems relationships, and operational excellence rather than primary care promotion. Career growth depends on successful launch execution and geographic expansion in low- and middle-income countries.
Regulatory Affairs Manager
Worked on LAMIVUDINE; STAVUDINE; NEVIRAPINE at Cipla? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.